Live Breaking News & Updates on India subject expert committee

Fact Check: Did India Ban the Pfizer COVID-19 Vaccine?


Fact Check: Did India Ban the Pfizer COVID-19 Vaccine?
On 2/18/21 at 10:48 AM EST
Governments around the world have launched mass vaccination campaigns in recent months to protect their citizens from COVID-19.
Multiple pharmaceutical companies have spearheaded vaccine development, including Pfizer-BioNTech, Moderna and Oxford/AstraZeneca, with each claiming strong efficacy following clinical trials.
Some countries have granted their chosen vaccines emergency use authorizations (EUA), giving the green light for distribution to start for those most at risk of the disease and frontline workers. For now, vaccine demand continues to exceed supply.
The Claim
Conspiracy theory website Infowars claimed on February 14, 2021, that India had banned the Pfizer-BioNTech vaccine due to safety concerns. On Thursday morning, there was a rise in Google web searches around the claim, such as India banned Pfizer vaccine and Pfizer vaccine banned in India. Twitter users also repeated the claim on that platform in the days after it was made.

Delhi , India , Hyderabad , Andhra-pradesh , Bharat , Oxford-astrazeneca , Alex-jones , Centers-for-disease , Google , India-subject-expert-committee , World-health-organization , Central-drugs-standard-control-organisation

Centre's COVID-19 vaccine communication strategy OUT amid wait for approval; Document here


Last Updated:
Centre s COVID-19 Vaccine Communication Strategy OUT Amid Wait For Approval; Document Here
The Health Ministry has released an 88-page document giving out details of its communication strategy to support the rollout of the COVID-19 vaccine in India.
The Union Ministry of Health and Family Welfare on Thursday released an 88-page document giving out details of its communication strategy to support the rollout of the COVID-19 vaccine in India. The introduction of the document says that the communication strategy that supports the COVID-19 vaccine rollout in India seeks to disseminate timely, accurate and transparent information about the vaccine(s) to alleviate apprehensions about the vaccine, ensure its acceptance and encourage uptake.

India , United-states , United-kingdom , American , Bharat , Jan-andolan , Union-health-ministry , Union-ministry-of-health , India-subject-expert-committee , National-media-rapid-response-cell , Health-ministry , Central-drugs-standard-control-organisation

Oxford vaccine gets UK nod, India seeks more data- The New Indian Express

Bharat Biotech, whose homegrown Covaxin has been developed in collaboration with the ICMR, is being tested on 26,000 people in late-stage trial.

India , United-kingdom , Bharat , Sumi-sukanya , Oxford-astrazeneca-covid , Pfizer , Astrazeneca , Serum-institute , India-subject-expert-committee , News-service , Serum-institute-of-india , Regulatory-agency